Glenn Oclassen Insider Profile
4 Followers
Glenn Oclassen, Director at Verrica Pharmaceuticals, holds 65.42K shares in Verrica Pharmaceuticals (Ticker: VRCA), holds 42.63K shares in Paratek Pharmaceuticals (Ticker: PRTK).
Glenn Oclassen's Trading History
| VRCAVerrica Pharmaceuticals | Jan 31, 2019 | Director | Uninformative Sell | ― | $232.90K | |
| PRTKParatek Pharmaceuticals | Oct 30, 2014 | ― | Uninformative Buy | 229.03K | $95.07K |
You May Also Like
Glenn Oclassen insider profile FAQ
What is the percentage of profitable transactions made by Glenn Oclassen?
The percentage of profitable transactions made by Glenn Oclassen is 25%.
What is the average return per transaction made by Glenn Oclassen?
The average return per transaction made by Glenn Oclassen is 5.60%.
What stocks does Glenn Oclassen hold?
Glenn Oclassen holds: VRCA, PRTK stocks.
What was Glenn Oclassen's most profitable transaction?
Glenn Oclassen’s most profitable transaction was an Informative Buy of PRTK stock on August 11, 2011. The return on the trade was 95.90%.
What is Glenn Oclassen's role in Verrica Pharmaceuticals?
Glenn Oclassen's role in Verrica Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
